Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH

6. NVDA
7. RKLB
8. CRM
9. CRWV
10. NOW

Citi Starts Mersana (MRSN) at Buy

November 15, 2024 4:52 AM EST

Citi analyst Yigal Nochomovitz initiates coverage on Mersana (NASDAQ: MRSN) with a Buy rating and a price target of $5.00.

The analyst comments "

MRSN expects to share initial data from the XMT-1660 (B7-H4 ADC) Ph1 by YE24. We see this readout as a... More